about
Deep brain stimulation for pantothenate kinase-associated neurodegeneration.Parkinson Disease: An Evolutionary PerspectiveRecommendations for the use of botulinum toxin type A in the management of cerebral palsy.Pharmacological options for the treatment of Tourette's disorder.Ancient descriptions of movement disorders: Cathedral el Burgo de Osma (Soria, Spain).Strategies for treatment of dystonia.Gait disturbances in Parkinson disease. Did freezing of gait exist before levodopa? Historical review.Task-specific dystonias: historical review--a new look at the classics.Art and dystonia.Practical management of adverse events related to apomorphine therapy.The high prevalence of impulse control behaviors in patients with early-onset Parkinson's disease: A cross-sectional multicenter study.Diversity of Cognitive Phenotypes Associated with C9ORF72 Hexanucleotide Expansion.Sleep attack associated to rotigotine.[Sleep attacks and pergolide mesylate][Short history of L-Dopa]Efficacy of long-term continuous subcutaneous apomorphine infusion in advanced Parkinson's disease with motor fluctuations: a multicenter study.Subthalamic lesion and paroxysmal tonic spasms.Very long-standing Parkinson's disease.Reaction time and rhythm of movement in Huntington's disease.Late onset Huntington's disease with 29 CAG repeat expansion.Senile chorea: a multicenter prospective study.Reply to: "Reply to Late onset Huntington's disease with 29 CAG repeat expansion" JNS-D-16-00732.Bradykinesia in Huntington's disease.Motor performance in patients with restless legs syndrome.[An 81-year-old female with paroxysmal dyskinesia of the tongue]Behavioral addictions in early-onset Parkinson disease are associated with DRD3 variants.Botulinum toxin treatment for spasmodic dysphonia: percutaneous versus transoral approach.'Spontaneous thalamotomy'.Impulse control disorder in patients with Parkinson's disease under dopamine agonist therapy: a multicentre study.Visual hallucinations and HLA class II antigens in cortical dementia.Efficacy and safety of pallidal stimulation in primary dystonia: results of the Spanish multicentric study.Cervical dystonia and Constantin Brancusi.Nocturnal subcutaneous apomorphine infusion for severe insomnia in Parkinson's disease.BDNF Val66Met polymorphism in primary adult-onset dystonia: a case-control study and meta-analysis.The fascinating case of Don Quixote.Deep brain stimulation holidays in essential tremor.Motor alterations are reduced in mice lacking the PARK2 gene in the presence of a human FTDP-17 mutant form of four-repeat tau.Evaluation of timed tests in advanced Parkinsonian patients who were candidates for subthalamic stimulation.Teaching NeuroImages: A rare case of giant perivascular spaces in the midbrain manifesting as atypical parkinsonism.[Amimia in Parkinson's disease. Significance and correlation with the clinical features].
P50
Q30625721-261E38E2-0D03-4A37-A5A2-2DCDF62609F1Q33619405-341803E1-4E98-4E14-B060-ACB3CA6AB2AAQ33831980-0CB8938D-34BA-413D-82A2-B41DB1023CB0Q34107470-C5255886-F2BE-4DB0-B08F-6F7D1DBC8F18Q34498954-1ABBD666-FDC6-47BB-956E-D3C847807279Q35775391-2348BFB0-5911-41BA-8BD4-AD382DBAB5A5Q37882815-33AC7F8F-EBD4-4ADB-90CB-ABC83C4C1307Q38050954-19270FE1-3D70-4B1D-91CE-F53354453E6FQ38413835-C357C68B-9A67-49A9-9D2C-6A812DEA40FEQ39029821-4D89E116-D687-43DB-BD82-6C8CC8FF8140Q40616513-2A60C394-F8F6-4718-8FAA-4B7FE72FCED6Q40859458-8A6B92F0-673E-431D-9F5D-106E483E3505Q43232497-A685A33C-8B65-4DCF-90EC-661DE0A70C96Q43547177-FAAB2A73-17BD-4B80-802B-B3C777A96B3DQ43952254-01BAD930-0362-42FE-A5F8-0288DA8AD676Q44438604-D0380E84-05E2-4913-9FEA-013511FE962EQ44669667-F1375DEF-9AC0-4957-B68A-3ECB10808BAEQ44972222-7DC188F3-E48C-497A-BDE6-E58890437925Q45293754-42CCC8DE-2706-4586-A6B3-570FBA65600CQ45293995-810D7C59-296D-43ED-B72C-53B870B37FF3Q45294014-E3F90E58-48AD-4DA8-A3B5-69E584505A5BQ45296337-E450A015-BBD9-4B84-A09E-8025593425F7Q45299914-747CA689-06D0-403D-A853-161AF123D23CQ45975111-10581DE4-25FD-48BA-B32E-3CBF8B5338AAQ46978723-85E9A1FB-6417-4FE7-8F8D-4D6CCCA909ABQ47552767-4FEE3D5D-276B-4CA5-8E9C-8A7D12A09EA5Q48002612-A7D12D1E-0B6D-41D9-B565-9D602A55C817Q48127436-CE40EEBE-D136-4C9E-9529-5E6A05D68D6BQ48333289-DFB83433-E34B-4840-A79D-6DB329095E54Q48350865-7EBFEED1-E629-4E01-8444-76E1A6297579Q48462365-DAEF3987-585C-4E62-8A7E-CFB08F3C2D16Q48485176-31A43B9F-BFA3-475F-A774-EFF056051E78Q48508653-D76B2374-3E41-477C-9186-9F5658D1170EQ48717867-87C94C64-70AC-4A57-9B54-3DCBFB112030Q48725877-B49A7BA5-F353-420A-AEB4-10D30EFF59B1Q48783009-7DCC280A-0C1C-4352-8CEA-D9FB53BDDC91Q48908523-9C1D973B-3C1D-49BE-9C5C-4A55011CB5D6Q49047878-CCE677E9-34C4-4891-81E0-184E3EC62A73Q50083049-C023E7B5-C39D-4BA9-8BA2-E046ED4A3FF0Q50093034-FBEAF343-9031-4E66-9B8E-218008E92C99
P50
description
investigador
@es
onderzoeker
@nl
researcher
@en
name
Pedro J Garcia Ruiz
@ast
Pedro J Garcia Ruiz
@en
Pedro J Garcia Ruiz
@es
Pedro J Garcia Ruiz
@nl
type
label
Pedro J Garcia Ruiz
@ast
Pedro J Garcia Ruiz
@en
Pedro J Garcia Ruiz
@es
Pedro J Garcia Ruiz
@nl
altLabel
García-Ruiz PJ
@en
P Garcia-Ruiz
@en
Pedro José García-Ruiz
@en
prefLabel
Pedro J Garcia Ruiz
@ast
Pedro J Garcia Ruiz
@en
Pedro J Garcia Ruiz
@es
Pedro J Garcia Ruiz
@nl
P1053
G-8660-2013
P106
P21
P2798
P31
P4012
P496
0000-0001-6194-672X